Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase EARLY_PHASE1 1

Status

Recruiting 3Completed 1

Sponsor Class

OTHER 3FED 1

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 5Tumor-Agnostic 4Thoracic 4Genitourinary 3Gastrointestinal 3Other hematologic neoplasm 2Gynecologic 2Lymphoid 1Dermatologic 1CNS 1

Conditions

Lung Neoplasms 3Tobacco Use Disorder 1Substance-Related Disorders 1Smoking 1Lung Cancer Screening 1

Interventions

Carboplatin 347pembrolizumab 322Pemetrexed 246Cisplatin 218Paclitaxel 147Nivolumab 138durvalumab 133osimertinib 112Docetaxel 111atezolizumab 109Specimen Handling 91Radiotherapy 87Drug Therapy 85Magnetic Resonance Spectroscopy 77Etoposide 76Radiosurgery 72Gemcitabine 71Ipilimumab 55130-nm albumin-bound paclitaxel 54Bevacizumab 52cemiplimab 47tislelizumab 44Blood Specimen Collection 40Cetuximab 35Taxes 34Platinum 33Injections 33Biopsy 33Standard of Care 31Immunoglobulin G 30

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Focus Groups × Thoracic × 1 year × Clear all
NCT07382557 2026-02-03

Adaptation and Pilot Testing of a Lung Cancer Screening Decision Aid for Patients From a Safety-Net Healthcare System

M.D. Anderson Cancer Center

Phase NA Recruiting
360 enrolled
Thoracic

Lung Neoplasms

NCT05833334 2026-01-30

HHS

Dartmouth-Hitchcock Medical Center

Phase NA Recruiting
172 enrolled
Thoracic

Lung Neoplasms, Smoking

NCT02914899 2025-11-21

Informing the Adaptation of a CHW Model to Facilitate Lung Cancer Screening for the Chinese Community

Memorial Sloan Kettering Cancer Center

Phase EARLY_PHASE1 Completed
99 enrolled
Thoracic

Lung Cancer Screening

NCT06432985 2025-09-30

CM_TUD_Cancer

VA Office of Research and Development

Phase NA Recruiting
108 enrolled
Thoracic

Lung Neoplasms, Tobacco Use Disorder, Substance-Related Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡